Relative Bioavailability of Phase II and Phase III Formulations of AZD0530

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00771979
First received: October 14, 2008
Last updated: June 17, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Estimated Primary Completion Date: No date given